[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576928":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":21,"responsibleParty":40,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Ain Shams Maternity Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"pregnant women with severe preeclampsia",null,"Preeclampsia with severe hypertension that does not respond to treatment or is associated with ongoing or recurring severe headaches, visual scotomata, nausea or vomiting, epigastric pain, oliguria, and severe hypertension, as well as progressive deterioration in laboratory blood tests such as rising creatinine or liver transaminases or falling platelet count, or failure of fetal growth or abnormal doppler findings.",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Rania HM Ahmed, MD","CONTACT","20201200522444","raneyah@med.asu.edu.eg",{"name":19,"role":15,"phone":10,"phoneExt":10,"email":20},"Sherif Ashoush, MD","sherifashoush@med.asu.edu.eg",[22],{"facility":23,"status":24,"city":25,"state":10,"zip":10,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Ain Shams University Maternity Hospital","RECRUITING","Cairo","Egypt","EG",{"type":29,"coordinates":30},"Point",[31,32],31.24967,30.06263,{"lat":32,"lon":31},[35,37],{"name":19,"role":15,"phone":36,"phoneExt":10,"email":20},"20201222660266",{"name":38,"role":39,"phone":10,"phoneExt":10,"email":10},"Ahmed Sakr","SUB_INVESTIGATOR",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":44,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Rania Hassan Mostafa","Dr","Ain Shams University","100576928","different-regimens-of-magnesium-sulphate-in-patients-with-severe-preeclampsia-100576928",false,"NCT06791668","Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia","Comparison of Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia in Ain Shams University Maternity Hospital (Retrospective Cohort)","Inclusion Criteria:\n\n* All hospital records of patients diagnosed as preeclampsia with severe features planned to receive magnesium sulphate.\n\nExclusion Criteria:\n\n* Records with missing data about the regimen of magnesium sulphate used","FEMALE","18 Years",{"count":55,"type":56},400,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. The main question this study aims to answer is:\n\nWhat are the different regimens of magnesium sulphate that are used to prevent seizures in pregnant women with severe pre-eclampsia?\n\nParticipants already have taken the magnesium sulphate as part of their regular medical care for severe pre-eclampsia. Researchers will look into the records of the participants in the past 5 years to collect the data.",[60],"Preeclampsia (PE)",[62,63,64,65],"eclampsia","magnesium sulphate","intensive care unit","pulmonary edema","2025-01-19",{"date":68,"type":69},"2025-01-24","ACTUAL",{"date":71,"type":69},"2024-12-03",{"date":73,"type":56},"2026-03",{"name":5,"class":6},1]